Krittiya Korphaisarn

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Wenting Liao, Michael J. Overman, Adam T. Boutin et al. · Cancer Cell · 2019 · 580 citations · Full text

Immune Therapy Resistance, Medicine, Immunology +7

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti–Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer

Kanwal Pratap Singh Raghav, Jonathan M. Loree, Jeffrey S. Morris et al. · JCO Precision Oncology · 2019 · 126 citations

<i>FBXW7</i> missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma

Krittiya Korphaisarn, Van K. Morris, Michael J. Overman et al. · Oncotarget · 2017 · 69 citations · Full text

Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin–cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study

Lucksamon Thamlikitkul, Vichien Srimuninnimit, Charuwan Akewanlop et al. · Supportive Care in Cancer · 2016 · 61 citations

Chemotherapy-induced Nausea, Breast Cancer Patients, Medicine +5